Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0J8EC
|
|||
| Former ID |
DIB002184
|
|||
| Drug Name |
ACT-280778
|
|||
| Indication | Essential hypertension [ICD-11: BA00; ICD-10: I10; ICD-9: 401] | Phase 2 | [1] | |
| Company |
Actelion Pharmaceuticals
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01264692) Essential Hypertension. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.